In the present study, we provided clinical, in vitro and animal evidences demonstrating that GSCs-derived ITGB8 exhibits anti-angiogenic effect on brain microvascular endothelial cells, and contributes to VM formation and EMT in GBM to support tumor invasion. This evidence concerns the gene ITGB8 and neoplasm.